Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
178.04 AUD | -0.63% | +2.41% | +58.54% |
Nov. 15 | Xero Poised for More Upside After 'Strong' Fiscal H1 Results, Jarden Research Says | MT |
Nov. 15 | Jarden Research Adjusts Xero's Price Target to AU$177 from AU$151, Keeps at Overweight | MT |
Evolution of the Average Target: Xero Limited
Evolution of the Target Price: Xero Limited
Changes in Analyst Recommendations: Xero Limited
Analyst Opinion | 4m Revision of opinion | Divergence of analysts' opinions | Divergence of Target Price | Ecart obj. / dr | ||
---|---|---|---|---|---|---|
+4.86% | ||||||
+10.82% | ||||||
-19.79% | ||||||
+8.45% | ||||||
+4.79% | ||||||
+9.82% | ||||||
-8.85% | ||||||
-3.37% | ||||||
+2.19% | ||||||
+4.50% | ||||||
Average | +1.34% | |||||
Weighted average by Cap. | +1.43% |
Analysts' Consensus
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
Jarden Research | |
Wilsons | |
RBC Capital Markets |
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- XRO Stock
- Consensus Xero Limited